Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Catalent Inc (NY: CTLT ) 58.23 +0.32 (+0.55%) Official Closing Price Updated: 7:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,923,147 Open 58.10 Bid (Size) 58.20 (1) Ask (Size) 58.99 (2) Prev. Close 57.91 Today's Range 57.80 - 58.25 52wk Range 31.80 - 60.20 Shares Outstanding 170,341,553 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Catalent Completes $25 Million Expansion of its Clinical Supply Facility in Schorndorf, Germany July 16, 2024 From Catalent, Inc. Via Business Wire Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty June 21, 2024 Catalent shares rise after Sarepta Therapeutics' Elevidys expanded approval. Despite uncertainties, Catalent's risk/reward profile improves. Via Benzinga Performance YTD +29.26% +29.26% 1 Month +3.06% +3.06% 3 Month +3.89% +3.89% 6 Month +16.88% +16.88% 1 Year +21.46% +21.46% More News Read More S&P 500 Giants Lead Five Healthy Stocks Near Buy Points June 01, 2024 Via Investor's Business Daily Topics Stocks Exposures US Equities Catalent Stockholders Approve Transaction with Novo Holdings May 29, 2024 From Catalent, Inc. Via Business Wire Beyond The Numbers: 6 Analysts Discuss Catalent Stock April 04, 2024 Via Benzinga (CTLT) - Analyzing Catalent's Short Interest February 28, 2024 Via Benzinga Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now? May 28, 2024 Via The Motley Fool Hedge Funds Tweak Portfolios In Q1: Marvell, TD Synnex, AES Get More Love As Focus Shifts To AI May 24, 2024 Via Benzinga CTLT Stock Earnings: Catalent Misses EPS, Misses Revenue for Q3 2024 May 09, 2024 Via InvestorPlace Catalent, Inc. Reports Third Quarter Fiscal 2024 Results May 08, 2024 From Catalent, Inc. Via Business Wire Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition May 02, 2024 Via Benzinga Robbins LLP Reminds Stockholders it is Investigating the Acquisition of Catalent, Inc. (CTLT) April 17, 2024 From Robbins LLP Via Business Wire Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform Rating April 12, 2024 Via Benzinga Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings April 10, 2024 From Robbins LLP Via GlobeNewswire Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics? March 26, 2024 Via The Motley Fool Week In Review: Three Multinationals Plan Investments In Southeast Asia Facilities March 23, 2024 Via Talk Markets Did Novo Nordisk Just Get a Jump on Eli Lilly? March 19, 2024 Via The Motley Fool Exposures Product Safety The Top 3 Pharma Stocks to Buy in March2024 March 09, 2024 Via InvestorPlace Novo Nordisk Sets Timeframe For Its Next-Gen Experimental Obesity Drug March 08, 2024 Via Benzinga Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment March 07, 2024 From Catalent, Inc. Via Business Wire Escalating Demand for Obesity Drugs Creates Time-Sensitive Race for Eli Lilly, Novo Nordisk March 06, 2024 Via Benzinga Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why March 05, 2024 Via The Motley Fool Record-High S&P 500 Propels SPY ETF To $500-Billion Milestone, Nvidia Tops $2 Trillion, Broadcom Surpasses Tesla March 01, 2024 Via Benzinga Topics ETFs Stocks Exposures US Equities Top Stocks Not Named Nvidia You Need To Know About In 2024: Here's What Investors Think About Them (Wall Street Vs. Reddit) February 29, 2024 Via Benzinga Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors February 26, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.